Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery

Related Experiment Video

Updated: Jun 10, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

N Dogra1, G D Puri, S S Rana

  • 1Advanced Cardiac Centre, Department of Anaesthesiology and Critical Care, PGIMER, Chandigarh, India. neeti_dogra@rediffmail.com

Perfusion
|August 14, 2010
PubMed

Insights

Successful anesthetic management for G6PD-deficient children undergoing cardiac surgery is possible. This study details safe perioperative strategies for glucose-6-phosphate dehydrogenase deficiency during cardiopulmonary bypass procedures.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Hematology

Background:

  • Cardiac surgery with cardiopulmonary bypass (CPB) can induce oxidative stress.
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency impairs red blood cell antioxidant defense.
  • Free radical production during CPB poses a risk of hemolysis in G6PD-deficient patients.

Observation:

  • Two pediatric patients with G6PD deficiency underwent cardiac surgery.
  • Anesthetic management was carefully planned and executed for both on- and off-CPB procedures.
  • No significant hemolytic reactions were observed post-operatively.

Findings:

  • Successful anesthetic management of G6PD-deficient children during cardiac surgery is achievable.
  • Specific perioperative strategies can mitigate the risk of hemolysis.
  • CPB can be safely utilized in G6PD-deficient patients with appropriate precautions.

Implications:

  • This case report provides valuable insights for managing G6PD deficiency in pediatric cardiac surgery.
  • It highlights the importance of tailored anesthetic protocols for patients with specific genetic conditions.
  • Further research into optimizing perioperative care for G6PD-deficient patients undergoing CPB is warranted.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Glycolysis: Preparatory Phase01:21

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy),  glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...